-
1
-
-
0033952711
-
Stapled versus sutured closure of loop ileostomy: a randomized controlled trial
-
Hasegawa H, Radley S, Morton DG, Keighley MR. Stapled versus sutured closure of loop ileostomy: a randomized controlled trial. Ann Surg 2000; 231: 202-4.
-
(2000)
Ann Surg
, vol.231
, pp. 202-204
-
-
Hasegawa, H.1
Radley, S.2
Morton, D.G.3
Keighley, M.R.4
-
2
-
-
16244392396
-
A prospective audit of the complications of loop ileostomy construction and takedown
-
Garcia-Botello SA, Garcia-Armengol J, Garcia-Granero E et al. A prospective audit of the complications of loop ileostomy construction and takedown. Dig Surg 2004; 21: 440-6.
-
(2004)
Dig Surg
, vol.21
, pp. 440-446
-
-
Garcia-Botello, S.A.1
Garcia-Armengol, J.2
Garcia-Granero, E.3
-
3
-
-
5644302181
-
Morbidity of temporary loop ileostomies
-
Bakx R, Busch OR, Bemelman WA, Veldink GL, Slors JF, Van Lanschot JJ. Morbidity of temporary loop ileostomies. Dig Surg 2004; 21: 277-81.
-
(2004)
Dig Surg
, vol.21
, pp. 277-281
-
-
Bakx, R.1
Busch, O.R.2
Bemelman, W.A.3
Veldink, G.L.4
Slors, J.F.5
Van Lanschot, J.J.6
-
4
-
-
2942668573
-
Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy
-
Colombel JF, Loftus EV Jr, Tremaine WJ et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004; 99: 878-83.
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 878-883
-
-
Colombel, J.F.1
Loftus Jr, E.V.2
Tremaine, W.J.3
-
5
-
-
11144357651
-
The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study
-
Marchal L, D'Haens G, Van Assche G et al. The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study. Aliment Pharmacol Ther 2004; 19: 749-54.
-
(2004)
Aliment Pharmacol Ther
, vol.19
, pp. 749-754
-
-
Marchal, L.1
D'Haens, G.2
Van Assche, G.3
-
6
-
-
35948929808
-
Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis?
-
Schluender SJ, Ippoliti A, Dubinsky M et al. Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis? Dis Colon Rectum 2007; 50: 1747-53.
-
(2007)
Dis Colon Rectum
, vol.50
, pp. 1747-1753
-
-
Schluender, S.J.1
Ippoliti, A.2
Dubinsky, M.3
-
7
-
-
34247469242
-
Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis
-
Selvasekar CR, Cima RR, Larson DW et al. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 2007; 204: 956-62.
-
(2007)
J Am Coll Surg
, vol.204
, pp. 956-962
-
-
Selvasekar, C.R.1
Cima, R.R.2
Larson, D.W.3
-
8
-
-
48349119531
-
Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy
-
Mor IJ, Vogel JD, da Luz Moreira A, Shen B, Hammel J, Remzi FH. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 2008; 51: 1202-10.
-
(2008)
Dis Colon Rectum
, vol.51
, pp. 1202-1210
-
-
Mor, I.J.1
Vogel, J.D.2
da Luz Moreira, A.3
Shen, B.4
Hammel, J.5
Remzi, F.H.6
-
9
-
-
0032851453
-
Factors affecting the incidence of postoperative septic complications and recurrence after strictureplasty for jejunoileal Crohn's disease
-
Yamamoto T, Keighley MR. Factors affecting the incidence of postoperative septic complications and recurrence after strictureplasty for jejunoileal Crohn's disease. Am J Surg 1999; 178: 240-5.
-
(1999)
Am J Surg
, vol.178
, pp. 240-245
-
-
Yamamoto, T.1
Keighley, M.R.2
-
10
-
-
2442668848
-
Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease
-
Sandborn WJ, Loftus EV. Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease. Gut 2004; 53: 780-2.
-
(2004)
Gut
, vol.53
, pp. 780-782
-
-
Sandborn, W.J.1
Loftus, E.V.2
-
12
-
-
0034785222
-
Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications
-
Hyde GM, Jewell DP, Kettlewell MGW, Mortensen NJMcC. Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications. Dis Colon Rectum 2001; 44: 1436-40.
-
(2001)
Dis Colon Rectum
, vol.44
, pp. 1436-1440
-
-
Hyde, G.M.1
Jewell, D.P.2
Kettlewell, M.G.W.3
Mortensen, N.J.M.4
-
14
-
-
0026074458
-
Risks of intestinal anastomoses in Crohn's disease
-
Post S, Betzler M, von Ditfurth B, Schürmann G, Küppers P, Herfarth C. Risks of intestinal anastomoses in Crohn's disease. Ann Surg 1991; 213: 37-42.
-
(1991)
Ann Surg
, vol.213
, pp. 37-42
-
-
Post, S.1
Betzler, M.2
von Ditfurth, B.3
Schürmann, G.4
Küppers, P.5
Herfarth, C.6
-
15
-
-
0020630735
-
Crohn's disease in a defined population course and results of surgical treatment. I. Small bowel disease
-
Lindhagen T, Ekelund G, Leandoer L, Hildell J, Lindström C, Wenckert A. Crohn's disease in a defined population course and results of surgical treatment. I. Small bowel disease. Acta Chir Scand 1983; 149: 407-13.
-
(1983)
Acta Chir Scand
, vol.149
, pp. 407-413
-
-
Lindhagen, T.1
Ekelund, G.2
Leandoer, L.3
Hildell, J.4
Lindström, C.5
Wenckert, A.6
-
16
-
-
0020541092
-
Crohn's disease in a defined population course and results of surgical treatment. Part II. Large bowel disease
-
Lindhagen T, Ekelund G, Leandoer L, Hildell J, Lindström C, Wenckert A. Crohn's disease in a defined population course and results of surgical treatment. Part II. Large bowel disease. Acta Chir Scand 1983; 149: 415-21.
-
(1983)
Acta Chir Scand
, vol.149
, pp. 415-421
-
-
Lindhagen, T.1
Ekelund, G.2
Leandoer, L.3
Hildell, J.4
Lindström, C.5
Wenckert, A.6
-
17
-
-
0017875564
-
Factors which influenced postoperative complications in patients with ulcerative colitis or Crohn's disease of the colon on corticosteroids
-
Allsop JR, Lee EC. Factors which influenced postoperative complications in patients with ulcerative colitis or Crohn's disease of the colon on corticosteroids. Gut 1978; 19: 729-34.
-
(1978)
Gut
, vol.19
, pp. 729-734
-
-
Allsop, J.R.1
Lee, E.C.2
-
18
-
-
0017160494
-
Early complications in patients previously treated with corticosteroids
-
Knudsen L, Christiansen L, Jarnum S. Early complications in patients previously treated with corticosteroids. Scand J Gastroenterol 1976; 37: 123-8.
-
(1976)
Scand J Gastroenterol
, vol.37
, pp. 123-128
-
-
Knudsen, L.1
Christiansen, L.2
Jarnum, S.3
-
19
-
-
0032923705
-
Tumor necrosis factor-alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis
-
Baert FJ, D'Haens GR, Peeters M et al. Tumor necrosis factor-alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 1999; 116: 22-8.
-
(1999)
Gastroenterology
, vol.116
, pp. 22-28
-
-
Baert, F.J.1
D'Haens, G.R.2
Peeters, M.3
-
20
-
-
0035810141
-
Invasive pulmonary aspergillosis associated with infliximab therapy
-
Warris A, Bjorneklett A, Gaustad P. Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 2001; 345: 1098-104.
-
(2001)
N Engl J Med
, vol.345
, pp. 1098-1104
-
-
Warris, A.1
Bjorneklett, A.2
Gaustad, P.3
-
21
-
-
2442696315
-
Infliximab in inflammatory bowel disease: clinical outcome in a population-based cohort from Stockholm County
-
Ljung T, Karlen P, Schmidt D et al. Infliximab in inflammatory bowel disease: clinical outcome in a population-based cohort from Stockholm County. Gut 2004; 53: 849-53.
-
(2004)
Gut
, vol.53
, pp. 849-853
-
-
Ljung, T.1
Karlen, P.2
Schmidt, D.3
-
22
-
-
33747008410
-
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
-
Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2006; 54: 2368-76.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 2368-2376
-
-
Dixon, W.G.1
Watson, K.2
Lunt, M.3
Hyrich, K.L.4
Silman, A.J.5
Symmons, D.P.6
-
23
-
-
34447521875
-
Anti-tumor necrosis factor α therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis
-
Schneeweiss S, Setoguchi S, Weinblatt ME et al. Anti-tumor necrosis factor α therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum 2007; 56: 1754-64.
-
(2007)
Arthritis Rheum
, vol.56
, pp. 1754-1764
-
-
Schneeweiss, S.1
Setoguchi, S.2
Weinblatt, M.E.3
-
24
-
-
28844473957
-
Infliximab for induction and maintenance therapy for ulcerative colitis
-
Rutgeerts P, Sandborn WJ, Feagan BG et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353: 2462-76.
-
(2005)
N Engl J Med
, vol.353
, pp. 2462-2476
-
-
Rutgeerts, P.1
Sandborn, W.J.2
Feagan, B.G.3
-
25
-
-
52549086464
-
Use of Infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients
-
Appau KA, Fazio VW, Shen B et al. Use of Infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients. J Gastrointest Surg 2008; 12: 1738-44.
-
(2008)
J Gastrointest Surg
, vol.12
, pp. 1738-1744
-
-
Appau, K.A.1
Fazio, V.W.2
Shen, B.3
-
26
-
-
27544455346
-
Complications of construction and closure of temporary loop ileostomy
-
Kaidar-Person O, Person B, Wexner SD. Complications of construction and closure of temporary loop ileostomy. J Am Coll Surg 2005; 201: 759-73.
-
(2005)
J Am Coll Surg
, vol.201
, pp. 759-773
-
-
Kaidar-Person, O.1
Person, B.2
Wexner, S.D.3
-
27
-
-
42449146667
-
Comparison of stapled versus handsewn loop ileostomy closure: a meta-analysis
-
Leung TT, MacLean AR, Buie WD, Dixon E. Comparison of stapled versus handsewn loop ileostomy closure: a meta-analysis. J Gastrointest Surg 2008; 5: 939-44.
-
(2008)
J Gastrointest Surg
, vol.5
, pp. 939-944
-
-
Leung, T.T.1
MacLean, A.R.2
Buie, W.D.3
Dixon, E.4
-
28
-
-
17744400294
-
Loop ileostomy closure after restorative proctocolectomy: outcome in 1504 patients
-
Wong KT, Remzi FH, Gorgun E et al. Loop ileostomy closure after restorative proctocolectomy: outcome in 1504 patients. Dis Colon Rectum 2005; 48: 243-50.
-
(2005)
Dis Colon Rectum
, vol.48
, pp. 243-250
-
-
Wong, K.T.1
Remzi, F.H.2
Gorgun, E.3
-
29
-
-
0026631133
-
One-stage estorative proctocolectomy without temporary defunctioning ileostomy
-
Sagar PM, Lewis W, Holdsworth PJ, Johnston D. One-stage estorative proctocolectomy without temporary defunctioning ileostomy. Dis Colon Rectum 1992; 35: 582-88.
-
(1992)
Dis Colon Rectum
, vol.35
, pp. 582-588
-
-
Sagar, P.M.1
Lewis, W.2
Holdsworth, P.J.3
Johnston, D.4
-
30
-
-
0027469843
-
Loop ileostomy is a safe option for fecal diversion
-
Wexner S, Taranow DA, Johansen OB, Itzkowitz F, Daniel N, Nogueras JJ et al. Loop ileostomy is a safe option for fecal diversion. Dis Colon Rectum 1993; 36: 349-354.
-
(1993)
Dis Colon Rectum
, vol.36
, pp. 349-354
-
-
Wexner, S.1
Taranow, D.A.2
Johansen, O.B.3
Itzkowitz, F.4
Daniel, N.5
Nogueras, J.J.6
-
31
-
-
34547485872
-
The impact of preoperative immunomodulation on pouch-related septic complications after ileal pouch-anal anastomosis
-
Lim M, Sagar P, Abdulgader A, Thekkinkattil D, Burke D. The impact of preoperative immunomodulation on pouch-related septic complications after ileal pouch-anal anastomosis. Dis Colon Rectum 2007; 50: 943-51.
-
(2007)
Dis Colon Rectum
, vol.50
, pp. 943-951
-
-
Lim, M.1
Sagar, P.2
Abdulgader, A.3
Thekkinkattil, D.4
Burke, D.5
|